Skip to main content
. Author manuscript; available in PMC: 2013 Jan 4.
Published in final edited form as: J Immunol. 2011 May 13;186(12):6683–6692. doi: 10.4049/jimmunol.1100525

Figure 7. Donor HSP90, HSP70 and calreticulin facilitate indirect presentation of class II-restricted HY alloantigen.

Figure 7

(a) B6 female mice were immunised with Hsf10Dby+, Hsf1+Dby+ or Hsf10Dby MEF. After 7d, IFNγ response by Th cells to pHY/Ab and pHX/Ab was determined by ex vivo ELISpot assay. Data represent 2 similar experiments using ~2—3 recipient mice per group per experiment; ± sem. (b) Donor 129/SvJ splenocytes were treated with pharmacological inhibitors for 3 hours and next extensively washed with PBS. B6 female mice were immunised with either DMSO (vehicle), geldanamycin (HSP90 inhibitor) or KNK437 (HSP70 inhibitor) treated male donor 129/SvJ splenocytes. After 7d, IFNγ response Th cells to pHY/Ab and pHX/Ab was assessed by ex vivo ELISpot assay. Data represent 3 similar experiments using ~2—3 recipient mice per group per experiment; ± sem. (c) Female B6 mice were immunised with CRT+Dby+, CRT0Dby+, CRT+Dby or CRT0Dby MEF. After 7d, IFNγ response by TH cells to pHY/Ab and pHX/Ab was determined as above. Data represent 3 similar experiments using ~3—4 recipient mice per group per experiment; ± sem.